The US Centers for Disease Control and Prevention (CDC) denies a request from several Western states to validate a new high-volume measles testing approach. California and Washington first asked the CDC in May to approve the method, but after about two months the CDC replied it could not proceed, citing “other competing priorities,” according to a letter described by both outlets.
The request is linked to preparations for major measles outbreaks. The states, acting through a West Coast health alliance, argue for rapid, high-throughput testing and also ask the CDC to develop protocols for evaluating other high-priority pathogens to strengthen outbreak readiness.
Across coverage, the core facts are consistent: a states’ coalition submitted the request, the CDC responded after roughly two months, and the reason given was competing priorities rather than details about the test itself. The reporting differs mainly in emphasis, with one outlet framing the response around CDC focus on emerging technologies and the other focusing on the fact the CDC ignored or declined the states’ validation request.
